Mark Kaganovich

Mark Kaganovich is the CEO and cofounder of SolveBio. Follow him on twitter at @markkaganovich.

Mark Kaganovich

Genomics will make the dream of targeted therapies a reality, which will have a massive health and economic impact. Yet most large life science enterprises, from pharma to providers, have…

Is enterprise genomics good enough yet?

Genomics has undergone a major shift in the last year. The drop in price in the past decade from $3B to $1K to sequence a genome is the 10X force…

Genomics Needs A Killer App